Quotient Sciences integrates drug substance into Translational Pharmaceutics Platform
The newly enhanced drug development platform will help empower innovators with the fastest development timelines
The newly enhanced drug development platform will help empower innovators with the fastest development timelines
AptarGroup acquired Voluntis and 80% of Weihai Hengyu Medical Products in 2021.
Dr. Peter Houghton will lead the research collaboration for GCCRI and is widely regarded as a leading expert in pediatric cancer research and in the development of novel approaches to treating childhood cancers
The three prequalified products are manufactured by the originator company, Roche, but the listings should pave the way for more companies coming forward to seek WHO prequalification
Laglo Soft lotion comes with a unique technology that enhances moisturisation and restructures the skin
Shilpa Biologicals has tie-ups with Zydus to supply ZyCoV-D vaccine drug substance and Dr Reddy’s to make Sputnik V from its facility in Dharwad
Urban, semi-urban and remote corners of the country will be catered using drone delivery technology
MedleyMed is present across the pharma and healthcare value chain. It offers digital solutions to all stake holders and is in the process of expanding its operations in India and USA. In an interview with Thomas C Thottathil, M Satyendra (Satish), Managing Director, Athena Global Technologies & MedleyMed discussed his plans and opportunities in India
The partnership includes multiple collaboration areas and is an important milestone for bringing cost-competitive biobased products to the market, with applications in the pharmaceutical, agricultural, cosmetics and personal care, and automotive industries
Under the terms of the agreement, Biogen will make an upfront payment of US $ 8 million to Xbrane
Subscribe To Our Newsletter & Stay Updated